Advertisement
+ News Categories + Corporate Categories + Report Categories

NEXT ARTICLE

FDA expects slow biosimilars ramp-up

12:19 EST 16 Dec 2011 | BioCentury

FDA expects to receive only one or two biosimilar marketing applications through the beginning of 2014, Theresa Mullin, director of FDA's Office of Planning and Informatics, told BioCentury Friday. She said FDA expects to issue draft biosimilars guid..

Related Biotechnology, Pharmaceutical and Healthcare News

Original Article: FDA expects slow biosimilars ramp-up

BioCentury

 Channels 9 Associated Channels :: Search

  • Biosimilars - news, reports, views and blogs

    Biosimilars or Follow-on biologics are terms used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusi...

  • Prostate Cancer Pub Med

    Prostate cancer is a form of cancer that develops in the prostate, a gland in the male reproductive system. Most prostate cancers are slow growing; however, there are cases of aggressive prostate ca...

  • Novartis

    Novartis is the fourth largest pharmaceutical company in the world, based on annual sales, which are exceeded $36,000m in 2009. Founded in 1996, Novartis focuses of four main areas; pharmaceuticals,...

  • Chronic Myelocytic Leukemia CML

    Chronic myelocytic leukemia is the resulting disease when neutrophil, basophil, eosinophil, and monocyte progenitors become cancerous. It is usually caused by the presence of the Philadelphia chromo...

  • Ventricular aneurysm

    Ventricular aneurysms are usually aftereffects of myocardial infarctions. When the heart muscle (cardiac muscle) partially dies during a heart attack, a layer of muscle may survive, and being severe...

  • AIDS and HIV

    AIDS; Acquired Immune Deficiency Syndrome. HIV; Human Immunodeficiency Virus HIV infection causes AIDS. HIV infection also causes the production of anti-HIV antibodies, which forms the test for...

  • Chronic Lymphocytic Leukemia CLL

    Chronic lymphocytic leukemia is a disease in which mature lymphocytes become cancerous and gradually replace normal cells in lymph nodes. CLL mainly affects elderly males in North America and Europe...

  • Macular Degeneration AMD

    Macular degeneration in the elderly (AMD) is a major cause of blindness. Its prevalence increases to 30% in patients 75 to 85 years of age. AMD occurs in two forms: dry and wet AMD. Central geograph...

  • Vascular Dementia

    Vascular Dementia accounts for 25% of all dementias (the second most commen cause after Alzheimers. It is the cumulative effects of many small strokes - patients often have evidence of vascular path...

Associated Content for this Article